William E Ashby, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 56 N College Ave Unit 2a, College Place, WA 99324 Phone: 509-529-4850 Fax: 509-525-5184 |
News Archive
The University of Texas MD Anderson Cancer Center has been awarded a grant to study whether xerostomia, a debilitating side effect caused by head and neck cancer radiation treatment, can be prevented when acupuncture is part of a patient's treatment regimen.
Today AFFiRiS AG announced an important step forward in the development of its vaccine for Parkinson's disease. The vaccine, known as PD01, has undergone numerous preclinical tests which have confirmed its principle of action ("Proof of Concept").
Progenics Pharmaceuticals, Inc. today announced that it plans to advance oral methylnaltrexone for the treatment of opioid-induced constipation (OIC) into late stage clinical development and will commence a phase 2b/3 clinical trial of a methylnaltrexone tablet in chronic-pain patients in the second half of 2010. Progenics also announced data from a clinical trial of this methylnaltrexone tablet.
In Iowa, the Republican presidential contenders tried to outdo one another in attacking reproductive rights as they sought the support of caucusgoers from the religious right. In New Hampshire, where voters are less socially conservative, the candidates have focused more on economic issues.
Migraines currently affect about 20 percent of the female population, and while these headaches are common, there are many unanswered questions surrounding this complex disease. Previous studies have linked this disorder to an increased risk of stroke and structural brain lesions, but it has remained unclear whether migraines had other negative consequences such as dementia or cognitive decline.
› Verified 2 days ago